Omisirge Approved for Patients With Blood Cancers to Reduce Infection Risk After Stem Cell Transplant

The FDA approved omidubicel-onlv (Omisirge, Gamida Cell), a substantially modified allogeneic (donor) cord ...

APRIL 19, 2023